Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer disease: A protocol of a randomized controlled trial.

Tytuł:
Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer disease: A protocol of a randomized controlled trial.
Autorzy:
Zhou K; Deyang Vocational College of Technology and Trade, Deyang, China.
He J
Quan L
Guo R
Źródło:
Medicine [Medicine (Baltimore)] 2022 Sep 30; Vol. 101 (39), pp. e30705.
Typ publikacji:
Clinical Trial Protocol; Journal Article
Język:
English
Imprint Name(s):
Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
MeSH Terms:
Acupuncture Therapy*/methods
Alzheimer Disease*/drug therapy
Humans ; Activities of Daily Living ; Donepezil/therapeutic use ; Double-Blind Method ; Homocysteine ; Prospective Studies ; Randomized Controlled Trials as Topic ; Single-Blind Method ; Superoxide Dismutase ; Treatment Outcome
References:
Zhang M, Xue B, Liu ZJ, et al. An overview of systematic reviews of acupuncture and moxibustion for Alzheimer’s disease. World Sci Technol. 2022;24:113–21.
Alzheimer’s Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11:332–84.
Penke B, Szűcs M, Bogár F. Oligomerization and conformational change turn monomeric β-amyloid and tau proteins toxic: their role in Alzheimer’s pathogenesis. Molecules. 2020;25:1–29.
Schneider LS, Mangialasche F, Andreasen N, et al. Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275:251–83.
Atri A, Shaughnessy LW, Locascio JJ, et al. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22:209–21.
Lanctôt KL, Herrmann N, Yau KK, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer’s disease: a meta-analysis. CMAJ. 2003;169:557–64.
Jia Y, Zhang X, Yu J, et al. Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial. BMC Complement Altern Med. 2017;17:556.
Jing-Ning YH, Xiang-Long M. East to west: research progress in traditional Chinese medicine for antiaging strategies. Trad Med Res. 2020;5:305.
Wang YY, Yu SF, Xue HY, et al. Effectiveness and safety of acupuncture for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Front Aging Neurosci. 2020;12:98.
Zhou J, Peng W, Xu M, et al. The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2015;94:e933.
Huang Q, Luo D, Chen L, et al. Effectiveness of acupuncture for Alzheimer’s disease: an updated systematic review and meta-analysis. Curr Med Sci. 2019;39:500–11.
Feng S, Li B, Zhang HN, et al. Placebo control and its methodological issues on clinical trials of acupuncture therapy. Chin Acup Moxibust. 2022;42:437–41.
Lee YS, Chae Y. Powerful effects of placebo needles. Acup Med. 2018;36:197–98.
Hall HA. Evidence lacking that acupuncture is more effective than placebo. Am Fam Physician. 2020;101:325–6.
Hu HT, Hu TY, Li BW, et al. Discussion of optimization of sham acupuncture setting based on a clinical trial about acupuncture treatment of migraine published in British Medical. J Acup Res. 2021;46:631–34.
MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Altern Complement Med (New York, NY). 2010;16:St1–14.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7:257–62.
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7:270–9.
The People’s Republic of China State Administration of traditional Chinese Medicine. Chinese Disease Diagnostic Efficacy Standards. Beijing: China Medical Science and Technology Press, 2012:165–70.
Porsteinsson AP, Grossberg GT, Mintzer J, et al. Memantine treatment in patients with mild to moderate Alzheimer’s disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res. 2008;5:83–9.
Galasko D, Schmitt F, Thomas R, et al. Detailed assessment of activities of daily living in moderate to severe Alzheimer’s disease. J Int Neuropsychol Soc. 2005;11:446–53.
Peng DT, Li H, Zhang ZJ. EFNS guidelines for the diagnosis and management of Alzheimer disease. Chin J Geriatr. 2011;30:89–95.
MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med. 2010;28:83–93.
Liu JH, Ma N, Dong X, et al. Research status and application analysis of placebo acupuncture control design. Shanghai J Acup Moxibust. 2022;41:318–22.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Wong A, Cheng ST, Lo ES, et al. Validity and reliability of the neuropsychiatric inventory questionnaire version in patients with stroke or transient ischemic attack having cognitive impairment. J Geriatr Psychiatry Neurol. 2014;27:247–52.
Tian Y, Wang X, Ai J. Research progress of Basal Forebrain Cholinergic in Alzheimer’s disease. Acta Neuropharmacologica. 2017;7:53–64.
Xue YH, Li DA, Li J. Clincical influence of Bushen Huatan Quyu recipe combined with donepezil hydrochloride on cognitive function, brain neurotrans-mitter and quality of life in patients with Alzheimer’s disease. Chin J Int Med Cardio Cerebrovasc Dis. 2019;17:2910–13.
Wang L, Chen ZL, Xu L, et al. Effect of scalp acupuncture combined with comprehensive rehabilitation training on cognitive function of patients with early Alzheimer’s disease. Liaoning J Trad Chin Med. 2022;49:178–81.
Tang Y, Wang T, Yang L, et al. Acupuncture for post-operative cognitive dysfunction: a systematic review and meta-analysis of randomized controlled trials. Acup Med. 2021;39:423–31.
Liu BC, Guo Y, Tian LX. Acupuncture – a national heritage of China to the world: international clinical research advances from the past decade. Acupunct Herb Med. 2021;1:65–73.
Wang Z, Liang P, Zhao Z, et al. Acupuncture modulates resting state hippocampal functional connectivity in Alzheimer disease. PLoS One. 2014;9:e91160.
Mou QJ, Jiang J, Wang X, et al. Research progress on the mechanism of acupuncture and moxibustion in the treatment of Alzheimer’s disease. World Sci Technol. 2020;22:2621–27.
Substance Nomenclature:
8SSC91326P (Donepezil)
0LVT1QZ0BA (Homocysteine)
EC 1.15.1.1 (Superoxide Dismutase)
Entry Date(s):
Date Created: 20221001 Date Completed: 20221104 Latest Revision: 20230103
Update Code:
20240105
PubMed Central ID:
PMC9524917
DOI:
10.1097/MD.0000000000030705
PMID:
36181104
Czasopismo naukowe
Background: Alzheimer disease (AD) is a common cause of dementia, and there are still a lack of treatment options to reverse or prevent disease progression. Existing evidence shows that acupuncture has advantages in the treatment of AD, but whether the efficacy of acupuncture belongs to the placebo effect remains controversial, and there is no strict placebo-controlled clinical study to evaluate the efficacy and safety of acupuncture combined with Western medicine in the treatment of AD.
Methods: This is a prospective randomized, a single-blind, sham-acupuncture controlled trial to study the clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate AD. Participants will be randomly divided into treatment and control groups. The treatment group using acupuncture combined with donepezil hydrochloride orally, and the control group using sham acupuncture combined with donepezil hydrochloride orally, followed up for 24 weeks after 24 weeks of continuous treatment. Outcome measures included: AD assessment scale-cognitive subscale, mini-mental state examination, activities of daily living, neuropsychiatric inventory questionnaire, serum superoxide dismutase, and homocysteine levels. Finally, SPASS 21.0 software was used for statistical analysis of the data.
Discussion: This study will evaluate the efficacy of acupuncture combined with Western medicine in improving cognitive function and activities of daily living in AD patients. The results of this study will verify whether the efficacy of acupuncture in the treatment of AD belongs to the placebo effect, which will also provide a reference for the clinical use of acupuncture combined with Western medicine in the treatment of AD.
Trial Registration: The TCTR identification number is TCTR20220817004.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies